Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Sagent Pharmaceuticals Announces Launch of ANEclear Device for Rapid Clearance of Inhaled Anesthetics Following Surgery

October 18, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

SCHAUMBURG, Ill., Oct. 18 /- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced the commercial launch of ANEclear ™ , an easy-to-use, disposable anesthesia recovery device at the American Society of Anesthesia (ASA) meeting in San Diego....

TOPICS:

Amgen to Review Results From TREAT and Propose Updates to ESA Labeling for Chronic Renal Failure Patients at an FDA Advisory Committee Meeting Today

October 18, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

THOUSAND OAKS, Calif., Oct. 18 /- Amgen (Nasdaq: AMGN ) will review the results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy) and will discuss how these results inform the appropriate use of erythropoiesis-stimulating agents (ESAs) for chronic renal...

TOPICS:

Fenwal Named Exclusive Provider of AccuVein's Award-Winning Vein Illumination Device for Blood and Plasma Centers

October 18, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

LAKE ZURICH, Ill., Oct. 18 /- Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today it has signed a three-year, exclusive agreement with AccuVein LLC to sell, market and distribute the AccuVein AV300...

TOPICS:
Advertisement

A new order for CPR, spelled C-A-B

October 18, 2010 6:31 am | by EurekAlert | News | Comments

(American Heart Association) The 2010 AHA Guidelines for CPR and ECC update the 2005 guidelines. When administering CPR, immediate chest compressions should be done first. Untrained lay people are urged to administer hands-only CPR (chest compressions only).

TOPICS:

Federal Register: Medical Device User Fees; Public Meeting; Extension of Comment Period

October 18, 2010 5:30 am | by U.S. Food & Drug Administration | News | Comments

The FDA is extending to November 1, 2010, the comment period for the notice that appeared in the Federal Register of August 13, 2010 (75 FR 49502).

TOPICS:

Federal Register: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Testing Communications on Medical Devices a...

October 18, 2010 5:30 am | by U.S. Food & Drug Administration | News | Comments

The FDA is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

TOPICS:

Rural/Metro subsidiaries plan $200M notes offering

October 18, 2010 4:45 am | by The Associated Press | News | Comments

Rural/Metro Corp., a provider of medical ambulance response services, said Monday that two of its subsidiaries plan to begin a private offering of $200 million senior notes due 2018.The issuers are Rural/Metro Operating Co. LLC and Rural/Metro (Delaware) Inc.The two units also plan to negotiate...

St. Jude agrees to buy AGA Medical for $1.04B

October 18, 2010 3:45 am | by The Associated Press | News | Comments

St. Jude Medical Inc. says it is buying rival heart device maker AGA Medical Holdings Inc. for $1.04 billion, or $20.80 per share.St. Jude is offering a premium of 41 percent compared to AGA's latest closing price. St. Jude is also taking on $225 million in debt held by AGA, and it says it...

Advertisement

Solta Medical acquires acne laser maker CLRS

October 18, 2010 3:45 am | by The Associated Press | News | Comments

Skin care device company Solta Medical Inc. said Monday it bought CLRS Technology, a California company that makes a device that treats acne using heat and light.Solta said it agreed to pay off about $1.1 million in CLRS debt and may make additional payments based on CLRS' sales and operating...

Cellectis In-Licenses Induced Pluripotent Stem Cell Technology From iPS Academia Japan

October 18, 2010 12:32 am | by Bio-Medicine.Org | News | Comments

PARIS and KYOTO, Japan, Oct. 18 /- Cellectis (Alternext: ALCLS), the French genome engineering specialist, and iPS Academia Japan Inc. (Kyoto, Japan) announced today that they have signed two separate non-exclusive agreements granting Cellectis worldwide access to the induced Pluripotent...

TOPICS:

S.D. Firms Discuss Future of Wireless Health in D.C.

October 17, 2010 11:31 pm | by San Diego Business Journal | News | Comments

With the digital dialogue between patient and provider promising brave new worlds and opportunities in health care and commerce, face-to-face meetings drew representatives from several San Diego startup medical device companies and a medical research organization advocating for wireless...

TOPICS:

Study documents wrong-site, wrong-patient procedure errors

October 17, 2010 10:30 pm | by EurekAlert | News | Comments

(JAMA and Archives Journals) Data from one liability insurance database in Colorado indicate that wrong-site and wrong-patient surgical and procedure errors continued to occur despite nationwide steps to help prevent them, according to a report in the October issue of Archives of Surgery,...

TOPICS:

Vaccine Leaders All Over the World Talking About China Vaccine Opportunities at VacChina 2010 -- the No.1 China Focused Vaccine Partnering Forum

October 17, 2010 8:33 pm | by Bio-Medicine.Org | News | Comments

SHANGHAI, Oct. 17 /PRNewswire-Asia/ -- At the end of 2009, the vaccine industry raised so much concern worldwide that the headlines of the business media were occupied by various kinds of news about vaccine enterprises. For example, Sinovac Biotech Co., Ltd. successfully landed on the...

TOPICS:

Experimental Drug Preserves Memory in Rodents

October 17, 2010 8:32 pm | by Massachusetts Institute of Technology | News | Comments

A new compound prevents age-related memory loss by blocking part of the stress system.

TOPICS:

Tocotrienols Shown to be Effective in Lowering Fat Levels in Blood

October 17, 2010 7:32 pm | by Bio-Medicine.Org | News | Comments

Tocotrienols Shown to be Effective in Lowering Fat Levels in Blood -- SINGAPORE, Oct. 17 /PRNewswire-Asia/ --

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading